Trefts E, Gannon M, Wasserman DH. The liver. Curr Biol. 2017;27:R1147–51.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Natarajan A, Wagner B, Sibilia M. The EGF receptor is required for efficient liver regeneration. Proc Natl Acad Sci USA. 2007;104:17081–6.

Borowiak M, Garratt AN, Wustefeld T, Strehle M, Trautwein C, Birchmeier C. Met provides essential signals for liver regeneration. Proc Natl Acad Sci USA. 2004;101:10608–13.

Zhao B, Li L, Lei Q, Guan KL. The Hippo-YAP pathway in organ size control and tumorigenesis: an updated version. Genes Dev. 2010;24:862–74.

Wu H, Wei L, Fan F, Ji S, Zhang S, Geng J. et al. Integration of Hippo signalling and the unfolded protein response to restrain liver overgrowth and tumorigenesis. Nat Commun. 2015;6:6239.

Gan W, Dai X, Dai X, Xie J, Yin S, Zhu J, et al. LATS suppresses mTORC1 activity to directly coordinate Hippo and mTORC1 pathways in growth control. Nat Cell Biol. 2020;22:246–56.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Han H, Nakaoka HJ, Hofmann L, Zhou JJ, Yu C, Zeng L. et al. The Hippo pathway kinases LATS1 and LATS2 attenuate cellular responses to heavy metals through phosphorylating MTF1. Nat Cell Biol. 2022;24:74–87.

Kim E, Kang JG, Kang MJ, Park JH, Kim YJ, Kweon TH. et al. O-GlcNAcylation on LATS2 disrupts the Hippo pathway by inhibiting its activity. Proc Natl Acad Sci USA. 2020;117:14259–69.

Dong J, Feldmann G, Huang J, Wu S, Zhang N, Comerford SA, et al. Elucidation of a universal size-control mechanism in Drosophila and mammals. Cell. 2007;130:1120–33.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Holden JK, Crawford JJ, Noland CL, Schmidt S, Zbieg JR, Lacap JA, et al. Small molecule dysregulation of TEAD lipidation induces a dominant-negative inhibition of Hippo pathway signaling. Cell Rep. 2020;31:107809.

Article  CAS  PubMed  Google Scholar 

Rozengurt E, Sinnett-Smith J, Eibl G. Yes-associated protein (YAP) in pancreatic cancer: at the epicenter of a targetable signaling network associated with patient survival. Signal Transduct Target Ther. 2018;3:11.

Yang D, Fu W, Li L, Xia X, Liao Q, Yue R, et al. Therapeutic effect of a novel Wnt pathway inhibitor on cardiac regeneration after myocardial infarction. Clin Sci. 2017;131:2919–32.

Article  CAS  Google Scholar 

Gill MK, Christova T, Zhang YY, Gregorieff A, Zhang L, Narimatsu M, et al. A feed forward loop enforces YAP/TAZ signaling during tumorigenesis. Nat Commun. 2018;9:3510.

Mooring M, Fowl BH, Lum S, Liu Y, Yao K, Softic S, et al. Hepatocyte stress increases expression of Yes-associated protein and transcriptional coactivator with PDZ-binding motif in hepatocytes to promote parenchymal inflammation and fibrosis. Hepatology. 2020;71:1813–30.

Ji S, Liu Q, Zhang S, Chen Q, Wang C, Zhang W, et al. FGF15 activates Hippo signaling to suppress bile acid metabolism and liver tumorigenesis. Dev Cell. 2019;48:460–74.

Thomann S, Weiler S, Marquard S, Rose F, Ball CR, Toth M, et al. YAP orchestrates heterotypic endothelial cell communication via HGF/c-MET signaling in liver tumorigenesis. Cancer Res. 2020;80:5502–14.

Nishio M, Sugimachi K, Goto H, Wang J, Morikawa T, Miyachi Y, et al. Dysregulated YAP1/TAZ and TGF-beta signaling mediate hepatocarcinogenesis in Mob1a/1b-deficient mice. Proc Natl Acad Sci USA. 2016;113:E71–80.

Liu Y, Lu T, Zhang C, Xu J, Xue Z, Busuttil RW. et al. Activation of YAP attenuates hepatic damage and fibrosis in liver ischemia-reperfusion injury. J Hepatol. 2019;71:719–30.

Fan F, He Z, Kong LL, Chen Q, Yuan Q, Zhang S, et al. Pharmacological targeting of kinases MST1 and MST2 augments tissue repair and regeneration. Sci Transl Med. 2016;8:108r–352r.

Article  Google Scholar 

Yu FX, Zhao B, Panupinthu N, Jewell JL, Lian I, Wang LH, et al. Regulation of the Hippo-YAP pathway by G-protein-coupled receptor signaling. Cell. 2012;150:780–91.

Lemmens S, Kusters L, Bronckaers A, Geurts N, Hendrix S. The beta2-adrenoceptor agonist terbutaline stimulates angiogenesis via Akt and ERK signaling. J Cell Physiol. 2017;232:298–308.

Article  CAS  PubMed  Google Scholar 

Tao X, Chen C, Chen Y, Zhang L, Hu J, Yu H, et al. β2-adrenergic receptor promotes liver regeneration partially through crosstalk with c-met. Cell Death Dis. 2022;13:571.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Shimizu T, Sugiura K, Sakai Y, Dar AR, Butcher RA, Matsumoto K, et al. Chemical signaling regulates axon regeneration via the GPCR-Gqα pathway in Caenorhabditis elegans. J Neurosci. 2022;42:720–30.

Giovanni S, Alessia P, Ece Y, Gaby EA, Maroun BS, Antimo G, et al. Bile acids signal via TGR5 to activate intestinal stem cells and epithelial regeneration. Gastroenterology. 2020;159:956–68.e8.

Article  Google Scholar 

Li J, Culman J, Hörtnagl H, Zhao Y, Gerova N, Timm M, et al. Angiotensin AT2 receptor protects against cerebral ischemia-induced neuronal injury. FASEB J. 2005;19:617–9.

Article  CAS  PubMed  Google Scholar 

Rompe F, Artuc M, Hallberg A, Alterman M, Ströder K, Thöne-Reineke C, et al. Direct angiotensin II type 2 receptor stimulation acts anti-inflammatory through epoxyeicosatrienoic acid and inhibition of nuclear factor kappaB. Hypertension. 2010;55:924–31.

Article  CAS  PubMed  Google Scholar 

Schwengel K, Namsolleck P, Lucht K, Clausen BH, Lambertsen KL, Valero-Esquitino V, et al. Angiotensin AT2-receptor stimulation improves survival and neurological outcome after experimental stroke in mice. J Mol Med. 2016;94:957–66.

Article  CAS  PubMed  Google Scholar 

Liu Q, Pan S, Liu S, Zhang S, Willerson JT, Martin JF, et al. Suppressing Hippo signaling in the stem cell niche promotes skeletal muscle regeneration. Stem Cells. 2021;39:737–49.

Mitchell C, Willenbring H. A reproducible and well-tolerated method for 2/3 partial hepatectomy in mice. Nat Protoc. 2008;3:1167–70.

Article  CAS  PubMed  Google Scholar 

Zhang Z, Yao T, Zhao N, Liu H, Cheng H, Gonzalez FJ. et al. Disruption of peroxisome proliferator-activated receptor alpha in hepatocytes protects against acetaminophen-induced liver injury by activating the IL-6/STAT3 pathway. Int J Biol Sci. 2022;18:2317–28.

Sun Z, Cade R, Zhang Z, Alouidor J, Van H. Angiotensinogen gene knockout delays and attenuates cold-induced hypertension. Hypertension. 2003;41:322–27.

Zhou YF, Song SS, Tian MX, Tang Z, Wang H, Fang Y, et al. Cystathionine beta-synthase mediated PRRX2/IL-6/STAT3 inactivation suppresses Tregs infiltration and induces apoptosis to inhibit HCC carcinogenesis. J Immunother Cancer. 2021;9:e003031.

Lu X, Wo G, Li B, Xu C, Wu J, Jiang C, et al. The anti-inflammatory NHE-06 restores antitumor immunity by targeting NF-kappaB/IL-6/STAT3 signaling in hepatocellular carcinoma. Biomed Pharmacother. 2018;102:420–27.

Article  CAS  PubMed  Google Scholar 

Russell JO, Camargo FD. Hippo signalling in the liver: role in development, regeneration and disease. Nat Rev Gastroenterol Hepatol. 2022;19:297–312.

Lu L, Finegold MJ, Johnson RL. Hippo pathway coactivators Yap and Taz are required to coordinate mammalian liver regeneration. Exp Mol Med. 2018;50:e423.

Article  PubMed  PubMed Central  Google Scholar 

Lai HS, Lin WH, Lai SL, Lin HY, Hsu WM, Chou CH, et al. Interleukin-6 mediates angiotensinogen gene expression during liver regeneration. PLoS One. 2013;8:e67868.

Cressman DE, Greenbaum LE, DeAngelis RA, Ciliberto G, Furth EE, Poli V, et al. Liver failure and defective hepatocyte regeneration in interleukin-6-deficient mice. Science. 1996;274:1379–83.

James LP, Lamps LW, McCullough S, Hinson JA. Interleukin 6 and hepatocyte regeneration in acetaminophen toxicity in the mouse. Biochem Biophys Res Commun. 2003;309:857–63.

Article  CAS  PubMed  Google Scholar 

Grady EF, Sechi LA, Griffin CA, Schambelan M, Kalinyak JE. Expression of AT2 receptors in the developing rat fetus. J Clin Invest. 1991;88:921–33.

Millan MA, Carvallo P, Izumi S, Zemel S, Catt KJ, Aguilera G. Novel sites of expression of functional angiotensin II receptors in the late gestation fetus. Science. 1989;244:1340–42.

Article  ADS  CAS  PubMed  Google Scholar 

Matsubara H. Pathophysiological role of angiotensin II type 2 receptor in cardiovascular and renal diseases. Circ Res. 1998;83:1182–91.

Ismael S, Ishrat T. Compound 21, a direct AT2R agonist, induces IL-10 and inhibits inflammation in mice following traumatic brain injury. Neuromol Med. 2022;24:274–8.

Article  CAS  Google Scholar 

Sharma N, Gaikwad AB. Ameliorative effect of AT2R and ACE2 activation on ischemic renal injury associated cardiac and hepatic dysfunction. Environ Toxicol Pharmacol. 2020;80:103501.

Article  CAS  PubMed  Google Scholar 

Li Y, Xiao D, Yang S, Zhang L. Promoter methylation represses AT2R gene and increases brain hypoxic-ischemic injury in neonatal rats. Neurobiol Dis. 2013;60:32–38.

Article  CAS  PubMed  Google Scholar 

Kaschina E, Namsolleck P, Unger T. AT2 receptors in cardiovascular and renal diseases. Pharmacol Res. 2017;125:39–47.

Article  CAS  PubMed  Google Scholar 

Yoshida T, Delafontaine P. An intronic enhancer element regulates angiotensin II type 2 receptor expression during satellite cell differentiation, and its activity is suppressed in congestive heart failure. J Biol Chem. 2016;291:25578–90.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Laflamme L, Gasparo M, Gallo JM, Payet MD, Gallo-Payet N. Angiotensin II induction of neurite outgrowth by AT2 receptors in NG108-15 cells. Effect counteracted by the AT1 receptors. J Biol Chem. 1996;271:22729–35.

Lucius R, Gallinat S, Rosenstiel P, Herdegen T, Sievers J, Unger T. The angiotensin II type 2 (AT2) receptor promotes axonal regeneration in the optic nerve of adult rats. J Exp Med. 1998;188:661–70.

Curato C, Slavic S, Dong J, Skorska A, Altarche-Xifro W, Miteva K, et al. Identification of noncytotoxic and IL-10-producing CD8+AT2R+ T cell population in response to ischemic heart injury. J Immunol. 2010;185:6286–93.

Xu XP, Huang LL, Hu SL, Han JB, He HL, Xu JY, et al. Genetic modification of mesenchymal stem cells overexpressing angiotensin II type 2 receptor increases cell migration to injured lung in LPS-induced acute lung injury mice. Stem Cells Transl Med. 2018;7:721–30.

Ali R, Patel S, Hussain T. Angiotensin type 2 receptor activation limits kidney injury during the early phase and induces Treg cells during the late phase of renal ischemia. Am J Physiol Ren Physiol. 2021;320:F814–25.

Article  CAS  Google Scholar